Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Atorvastatin Calcium Market 2018, Forecast to 2023

Publisher Name :
Date: 09-Jul-2018
No. of pages: 154

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.

Scope of the Report:

This report focuses on the Atorvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.

India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.

The worldwide market for Atorvastatin Calcium is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 230 million US$ in 2023, from 160 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Pfizer

- DSM Sinochem Pharmaceuticals

- Cadila Pharmaceuticals

- Sun Pharmaceutical Industries

- Dr. Reddy's

- Morepen

- Teva Pharmaceutical Industries

- Apotex Pharmachem

- Sandoz Inc

- Mylan Pharmaceuticals Inc.

- Kremers Urban Pharmaceuticals Inc.

- ScieGen Pharmaceuticals, Inc.

- Zheijang Neo-Dankon Pharmaceutical

- Ningbo Menovo Pharmaceuticals Group

- Jialin Pharmaceutical

- Topfond

- Zhejiang Hisun Pharmacutical

- Zhejiang Hongyuan Pharmaceutical

- Hubei Yitai Pharmaceutical

- Jiangsu Hengrui Medicine

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Chemical Synthesis

- Biocatalysis

- Others

Market Segment by Applications, can be divided into

- Tablet (Including Dispersible Tablet and General Tablet)

- Capsule

- Others

There are 15 Chapters to deeply display the global Atorvastatin Calcium market.

Chapter 1, to describe Atorvastatin Calcium Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Atorvastatin Calcium, with sales, revenue, and price of Atorvastatin Calcium, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Atorvastatin Calcium, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Atorvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Atorvastatin Calcium sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Atorvastatin Calcium Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Atorvastatin Calcium Introduction
1.2 Market Analysis by Type
1.2.1 Chemical Synthesis
1.2.2 Biocatalysis
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Tablet (Including Dispersible Tablet and General Tablet)
1.3.2 Capsule
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Atorvastatin Calcium Product Introduction
2.1.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.1.2.2 Atorvastatin Calcium Product Information
2.1.3 Pfizer Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Atorvastatin Calcium Market Share in 2017
2.2 DSM Sinochem Pharmaceuticals
2.2.1 Business Overview
2.2.1.1 DSM Sinochem Pharmaceuticals Description
2.2.1.2 DSM Sinochem Pharmaceuticals Headquarter, Main Business and Finance Overview
2.2.2 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product Introduction
2.2.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.2.2.2 Atorvastatin Calcium Product Information
2.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global DSM Sinochem Pharmaceuticals Atorvastatin Calcium Market Share in 2017
2.3 Cadila Pharmaceuticals
2.3.1 Business Overview
2.3.1.1 Cadila Pharmaceuticals Description
2.3.1.2 Cadila Pharmaceuticals Headquarter, Main Business and Finance Overview
2.3.2 Cadila Pharmaceuticals Atorvastatin Calcium Product Introduction
2.3.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.3.2.2 Atorvastatin Calcium Product Information
2.3.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Cadila Pharmaceuticals Atorvastatin Calcium Market Share in 2017
2.4 Sun Pharmaceutical Industries
2.4.1 Business Overview
2.4.1.1 Sun Pharmaceutical Industries Description
2.4.1.2 Sun Pharmaceutical Industries Headquarter, Main Business and Finance Overview
2.4.2 Sun Pharmaceutical Industries Atorvastatin Calcium Product Introduction
2.4.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.4.2.2 Atorvastatin Calcium Product Information
2.4.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sun Pharmaceutical Industries Atorvastatin Calcium Market Share in 2017
2.5 Dr. Reddy's
2.5.1 Business Overview
2.5.1.1 Dr. Reddy's Description
2.5.1.2 Dr. Reddy's Headquarter, Main Business and Finance Overview
2.5.2 Dr. Reddy's Atorvastatin Calcium Product Introduction
2.5.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.5.2.2 Atorvastatin Calcium Product Information
2.5.3 Dr. Reddy's Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Dr. Reddy's Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Dr. Reddy's Atorvastatin Calcium Market Share in 2017
2.6 Morepen
2.6.1 Business Overview
2.6.1.1 Morepen Description
2.6.1.2 Morepen Headquarter, Main Business and Finance Overview
2.6.2 Morepen Atorvastatin Calcium Product Introduction
2.6.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.6.2.2 Atorvastatin Calcium Product Information
2.6.3 Morepen Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Morepen Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Morepen Atorvastatin Calcium Market Share in 2017
2.7 Teva Pharmaceutical Industries
2.7.1 Business Overview
2.7.1.1 Teva Pharmaceutical Industries Description
2.7.1.2 Teva Pharmaceutical Industries Headquarter, Main Business and Finance Overview
2.7.2 Teva Pharmaceutical Industries Atorvastatin Calcium Product Introduction
2.7.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.7.2.2 Atorvastatin Calcium Product Information
2.7.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Teva Pharmaceutical Industries Atorvastatin Calcium Market Share in 2017
2.8 Apotex Pharmachem
2.8.1 Business Overview
2.8.1.1 Apotex Pharmachem Description
2.8.1.2 Apotex Pharmachem Headquarter, Main Business and Finance Overview
2.8.2 Apotex Pharmachem Atorvastatin Calcium Product Introduction
2.8.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.8.2.2 Atorvastatin Calcium Product Information
2.8.3 Apotex Pharmachem Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Apotex Pharmachem Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Apotex Pharmachem Atorvastatin Calcium Market Share in 2017
2.9 Sandoz Inc
2.9.1 Business Overview
2.9.1.1 Sandoz Inc Description
2.9.1.2 Sandoz Inc Headquarter, Main Business and Finance Overview
2.9.2 Sandoz Inc Atorvastatin Calcium Product Introduction
2.9.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.9.2.2 Atorvastatin Calcium Product Information
2.9.3 Sandoz Inc Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Sandoz Inc Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Sandoz Inc Atorvastatin Calcium Market Share in 2017
2.10 Mylan Pharmaceuticals Inc.
2.10.1 Business Overview
2.10.1.1 Mylan Pharmaceuticals Inc. Description
2.10.1.2 Mylan Pharmaceuticals Inc. Headquarter, Main Business and Finance Overview
2.10.2 Mylan Pharmaceuticals Inc. Atorvastatin Calcium Product Introduction
2.10.2.1 Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
2.10.2.2 Atorvastatin Calcium Product Information
2.10.3 Mylan Pharmaceuticals Inc. Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Mylan Pharmaceuticals Inc. Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Mylan Pharmaceuticals Inc. Atorvastatin Calcium Market Share in 2017
2.11 Kremers Urban Pharmaceuticals Inc.
2.11.1 Business Overview
2.11.2 Kremers Urban Pharmaceuticals Inc. Atorvastatin Calcium Product Introduction
2.11.3 Kremers Urban Pharmaceuticals Inc. Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 ScieGen Pharmaceuticals, Inc.
2.12.1 Business Overview
2.12.2 ScieGen Pharmaceuticals, Inc. Atorvastatin Calcium Product Introduction
2.12.3 ScieGen Pharmaceuticals, Inc. Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Zheijang Neo-Dankon Pharmaceutical
2.13.1 Business Overview
2.13.2 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product Introduction
2.13.3 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Ningbo Menovo Pharmaceuticals Group
2.14.1 Business Overview
2.14.2 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product Introduction
2.14.3 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Jialin Pharmaceutical
2.15.1 Business Overview
2.15.2 Jialin Pharmaceutical Atorvastatin Calcium Product Introduction
2.15.3 Jialin Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Topfond
2.16.1 Business Overview
2.16.2 Topfond Atorvastatin Calcium Product Introduction
2.16.3 Topfond Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Zhejiang Hisun Pharmacutical
2.17.1 Business Overview
2.17.2 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product Introduction
2.17.3 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Zhejiang Hongyuan Pharmaceutical
2.18.1 Business Overview
2.18.2 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product Introduction
2.18.3 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Hubei Yitai Pharmaceutical
2.19.1 Business Overview
2.19.2 Hubei Yitai Pharmaceutical Atorvastatin Calcium Product Introduction
2.19.3 Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Jiangsu Hengrui Medicine
2.20.1 Business Overview
2.20.2 Jiangsu Hengrui Medicine Atorvastatin Calcium Product Introduction
2.20.3 Jiangsu Hengrui Medicine Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Atorvastatin Calcium Market Competition, by Manufacturer
3.1 Global Atorvastatin Calcium Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Atorvastatin Calcium Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Atorvastatin Calcium Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Atorvastatin Calcium Manufacturer Market Share in 2017
3.4.2 Top 5 Atorvastatin Calcium Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Atorvastatin Calcium Market Analysis by Regions
4.1 Global Atorvastatin Calcium Sales, Revenue and Market Share by Regions
4.1.1 Global Atorvastatin Calcium Sales by Regions (2013-2018)
4.1.2 Global Atorvastatin Calcium Revenue by Regions (2013-2018)
4.2 North America Atorvastatin Calcium Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Atorvastatin Calcium Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Atorvastatin Calcium Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Atorvastatin Calcium Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Atorvastatin Calcium Sales, Revenue and Growth Rate (2013-2018)
5 North America Atorvastatin Calcium by Countries, Type, Application and Manufacturers
5.1 North America Atorvastatin Calcium Sales, Revenue and Market Share by Countries
5.1.1 North America Atorvastatin Calcium Sales by Countries (2013-2018)
5.1.2 North America Atorvastatin Calcium Revenue by Countries (2013-2018)
5.1.3 United States Atorvastatin Calcium Sales and Growth Rate (2013-2018)
5.1.4 Canada Atorvastatin Calcium Sales and Growth Rate (2013-2018)
5.1.5 Mexico Atorvastatin Calcium Sales and Growth Rate (2013-2018)
5.2 North America Atorvastatin Calcium Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Atorvastatin Calcium Sales by Manufacturers (2016-2017)
5.2.2 North America Atorvastatin Calcium Revenue by Manufacturers (2016-2017)
5.3 North America Atorvastatin Calcium Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Atorvastatin Calcium Sales and Sales Share by Type (2013-2018)
5.3.2 North America Atorvastatin Calcium Revenue and Revenue Share by Type (2013-2018)
5.4 North America Atorvastatin Calcium Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Atorvastatin Calcium Sales and Sales Share by Application (2013-2018)
5.4.2 North America Atorvastatin Calcium Revenue and Revenue Share by Application (2013-2018)
6 Europe Atorvastatin Calcium by Countries, Type, Application and Manufacturers
6.1 Europe Atorvastatin Calcium Sales, Revenue and Market Share by Countries
6.1.1 Europe Atorvastatin Calcium Sales by Countries (2013-2018)
6.1.2 Europe Atorvastatin Calcium Revenue by Countries (2013-2018)
6.1.3 Germany Atorvastatin Calcium Sales and Growth Rate (2013-2018)
6.1.4 UK Atorvastatin Calcium Sales and Growth Rate (2013-2018)
6.1.5 France Atorvastatin Calcium Sales and Growth Rate (2013-2018)
6.1.6 Russia Atorvastatin Calcium Sales and Growth Rate (2013-2018)
6.1.7 Italy Atorvastatin Calcium Sales and Growth Rate (2013-2018)
6.2 Europe Atorvastatin Calcium Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Atorvastatin Calcium Sales by Manufacturers (2016-2017)
6.2.2 Europe Atorvastatin Calcium Revenue by Manufacturers (2016-2017)
6.3 Europe Atorvastatin Calcium Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Atorvastatin Calcium Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Atorvastatin Calcium Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Atorvastatin Calcium Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Atorvastatin Calcium Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Atorvastatin Calcium Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Atorvastatin Calcium by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Atorvastatin Calcium Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Atorvastatin Calcium Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Atorvastatin Calcium Revenue by Countries (2013-2018)
7.1.3 China Atorvastatin Calcium Sales and Growth Rate (2013-2018)
7.1.4 Japan Atorvastatin Calcium Sales and Growth Rate (2013-2018)
7.1.5 Korea Atorvastatin Calcium Sales and Growth Rate (2013-2018)
7.1.6 India Atorvastatin Calcium Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Atorvastatin Calcium Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Atorvastatin Calcium Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Atorvastatin Calcium Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Atorvastatin Calcium Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Atorvastatin Calcium Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Atorvastatin Calcium Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Atorvastatin Calcium Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Atorvastatin Calcium Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Atorvastatin Calcium Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Atorvastatin Calcium Revenue and Revenue Share by Application (2013-2018)
8 South America Atorvastatin Calcium by Countries, Type, Application and Manufacturers
8.1 South America Atorvastatin Calcium Sales, Revenue and Market Share by Countries
8.1.1 South America Atorvastatin Calcium Sales by Countries (2013-2018)
8.1.2 South America Atorvastatin Calcium Revenue by Countries (2013-2018)
8.1.3 Brazil Atorvastatin Calcium Sales and Growth Rate (2013-2018)
8.1.4 Argentina Atorvastatin Calcium Sales and Growth Rate (2013-2018)
8.1.5 Colombia Atorvastatin Calcium Sales and Growth Rate (2013-2018)
8.2 South America Atorvastatin Calcium Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Atorvastatin Calcium Sales by Manufacturers (2016-2017)
8.2.2 South America Atorvastatin Calcium Revenue by Manufacturers (2016-2017)
8.3 South America Atorvastatin Calcium Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Atorvastatin Calcium Sales and Sales Share by Type (2013-2018)
8.3.2 South America Atorvastatin Calcium Revenue and Revenue Share by Type (2013-2018)
8.4 South America Atorvastatin Calcium Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Atorvastatin Calcium Sales and Sales Share by Application (2013-2018)
8.4.2 South America Atorvastatin Calcium Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Atorvastatin Calcium by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Atorvastatin Calcium Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Atorvastatin Calcium Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Atorvastatin Calcium Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Atorvastatin Calcium Sales and Growth Rate (2013-2018)
9.1.4 UAE Atorvastatin Calcium Sales and Growth Rate (2013-2018)
9.1.5 Egypt Atorvastatin Calcium Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Atorvastatin Calcium Sales and Growth Rate (2013-2018)
9.1.7 South Africa Atorvastatin Calcium Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Atorvastatin Calcium Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Atorvastatin Calcium Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Atorvastatin Calcium Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Atorvastatin Calcium Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Atorvastatin Calcium Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Atorvastatin Calcium Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Atorvastatin Calcium Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Atorvastatin Calcium Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Atorvastatin Calcium Revenue and Revenue Share by Application (2013-2018)
10 Global Atorvastatin Calcium Market Segment by Type
10.1 Global Atorvastatin Calcium Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Atorvastatin Calcium Sales and Market Share by Type (2013-2018)
10.1.2 Global Atorvastatin Calcium Revenue and Market Share by Type (2013-2018)
10.2 Chemical Synthesis Sales Growth and Price
10.2.1 Global Chemical Synthesis Sales Growth (2013-2018)
10.2.2 Global Chemical Synthesis Price (2013-2018)
10.3 Biocatalysis Sales Growth and Price
10.3.1 Global Biocatalysis Sales Growth (2013-2018)
10.3.2 Global Biocatalysis Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Atorvastatin Calcium Market Segment by Application
11.1 Global Atorvastatin Calcium Sales Market Share by Application (2013-2018)
11.2 Tablet (Including Dispersible Tablet and General Tablet) Sales Growth (2013-2018)
11.3 Capsule Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Atorvastatin Calcium Market Forecast (2018-2023)
12.1 Global Atorvastatin Calcium Sales, Revenue and Growth Rate (2018-2023)
12.2 Atorvastatin Calcium Market Forecast by Regions (2018-2023)
12.2.1 North America Atorvastatin Calcium Market Forecast (2018-2023)
12.2.2 Europe Atorvastatin Calcium Market Forecast (2018-2023)
12.2.3 Asia-Pacific Atorvastatin Calcium Market Forecast (2018-2023)
12.2.4 South America Atorvastatin Calcium Market Forecast (2018-2023)
12.2.5 Middle East and Africa Atorvastatin Calcium Market Forecast (2018-2023)
12.3 Atorvastatin Calcium Market Forecast by Type (2018-2023)
12.3.1 Global Atorvastatin Calcium Sales Forecast by Type (2018-2023)
12.3.2 Global Atorvastatin Calcium Market Share Forecast by Type (2018-2023)
12.4 Atorvastatin Calcium Market Forecast by Application (2018-2023)
12.4.1 Global Atorvastatin Calcium Sales Forecast by Application (2018-2023)
12.4.2 Global Atorvastatin Calcium Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Atorvastatin Calcium Picture
Table Product Specifications of Atorvastatin Calcium
Figure Global Atorvastatin Calcium CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Atorvastatin Calcium CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Atorvastatin Calcium by Types in 2017
Figure Chemical Synthesis Picture
Table Major Manufacturers of Chemical Synthesis
Figure Biocatalysis Picture
Table Major Manufacturers of Biocatalysis
Figure Others Picture
Table Major Manufacturers of Others
Figure Atorvastatin Calcium Sales Market Share by Applications in 2017
Figure Tablet (Including Dispersible Tablet and General Tablet) Picture
Figure Capsule Picture
Figure Others Picture
Figure United States Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure France Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure UK Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure China Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure India Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Atorvastatin Calcium Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Pfizer Atorvastatin Calcium Product
Table Pfizer Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Atorvastatin Calcium Sales Market Share in 2017
Figure Global Pfizer Atorvastatin Calcium Revenue Market Share in 2017
Table DSM Sinochem Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table DSM Sinochem Pharmaceuticals Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product
Table DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales Market Share in 2017
Figure Global DSM Sinochem Pharmaceuticals Atorvastatin Calcium Revenue Market Share in 2017
Table Cadila Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Cadila Pharmaceuticals Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Cadila Pharmaceuticals Atorvastatin Calcium Product
Table Cadila Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cadila Pharmaceuticals Atorvastatin Calcium Sales Market Share in 2017
Figure Global Cadila Pharmaceuticals Atorvastatin Calcium Revenue Market Share in 2017
Table Sun Pharmaceutical Industries Headquarter, Established, Main Business and Finance Overview (2017)
Table Sun Pharmaceutical Industries Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Sun Pharmaceutical Industries Atorvastatin Calcium Product
Table Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sun Pharmaceutical Industries Atorvastatin Calcium Sales Market Share in 2017
Figure Global Sun Pharmaceutical Industries Atorvastatin Calcium Revenue Market Share in 2017
Table Dr. Reddy's Headquarter, Established, Main Business and Finance Overview (2017)
Table Dr. Reddy's Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Dr. Reddy's Atorvastatin Calcium Product
Table Dr. Reddy's Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Dr. Reddy's Atorvastatin Calcium Sales Market Share in 2017
Figure Global Dr. Reddy's Atorvastatin Calcium Revenue Market Share in 2017
Table Morepen Headquarter, Established, Main Business and Finance Overview (2017)
Table Morepen Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Morepen Atorvastatin Calcium Product
Table Morepen Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Morepen Atorvastatin Calcium Sales Market Share in 2017
Figure Global Morepen Atorvastatin Calcium Revenue Market Share in 2017
Table Teva Pharmaceutical Industries Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Pharmaceutical Industries Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Teva Pharmaceutical Industries Atorvastatin Calcium Product
Table Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Pharmaceutical Industries Atorvastatin Calcium Sales Market Share in 2017
Figure Global Teva Pharmaceutical Industries Atorvastatin Calcium Revenue Market Share in 2017
Table Apotex Pharmachem Headquarter, Established, Main Business and Finance Overview (2017)
Table Apotex Pharmachem Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Apotex Pharmachem Atorvastatin Calcium Product
Table Apotex Pharmachem Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Apotex Pharmachem Atorvastatin Calcium Sales Market Share in 2017
Figure Global Apotex Pharmachem Atorvastatin Calcium Revenue Market Share in 2017
Table Sandoz Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Sandoz Inc Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Sandoz Inc Atorvastatin Calcium Product
Table Sandoz Inc Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sandoz Inc Atorvastatin Calcium Sales Market Share in 2017
Figure Global Sandoz Inc Atorvastatin Calcium Revenue Market Share in 2017
Table Mylan Pharmaceuticals Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Pharmaceuticals Inc. Atorvastatin Calcium Production Bases, Sales Regions and Major Competitors
Table Mylan Pharmaceuticals Inc. Atorvastatin Calcium Product
Table Mylan Pharmaceuticals Inc. Atorvastatin Calcium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Pharmaceuticals Inc. Atorvastatin Calcium Sales Market Share in 2017
Figure Global Mylan Pharmaceuticals Inc. Atorvastatin Calcium Revenue Market Share in 2017
Table Kremers Urban Pharmaceuticals Inc.
Table Kremers Urban Pharmaceuticals Inc. Atorvastatin Calcium
Table ScieGen Pharmaceuticals, Inc.
Table ScieGen Pharmaceuticals, Inc. Atorvastatin Calcium
Table Zheijang Neo-Dankon Pharmaceutical
Table Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium
Table Ningbo Menovo Pharmaceuticals Group
Table Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium
Table Jialin Pharmaceutical
Table Jialin Pharmaceutical Atorvastatin Calcium
Table Topfond
Table Topfond Atorvastatin Calcium
Table Zhejiang Hisun Pharmacutical
Table Zhejiang Hisun Pharmacutical Atorvastatin Calcium
Table Zhejiang Hongyuan Pharmaceutical
Table Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium
Table Hubei Yitai Pharmaceutical
Table Hubei Yitai Pharmaceutical Atorvastatin Calcium
Table Jiangsu Hengrui Medicine
Table Jiangsu Hengrui Medicine Atorvastatin Calcium
Table Global Atorvastatin Calcium Sales by Manufacturer (2016-2017)
Figure Global Atorvastatin Calcium Sales Market Share by Manufacturer in 2016
Figure Global Atorvastatin Calciu
  • Global Rosuvastatin Market Insights, Forecast to 2025
    Published: 14-Sep-2018        Price: US 3900 Onwards        Pages: 126
    This report studies the global market size of Rosuvastatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rosuvastatin in these regions. This research report categorizes the global Rosuvastatin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and cha......
  • Angina (Angina Pectoris) - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 71
    Angina (Angina Pectoris) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H2 2018, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape. Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is relieved by rest. Angina generally is a symptom of cor......
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 196
    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial Disease Peripheral Vascular Disease - Pipeline Review, H2 2018, provides an overview of the Peripheral Arterial Disease Peripheral Vascular Disease (Cardiovascular) pipeline landscape. Peripheral vascular disease (PVD) refers to diseases of the blood ve......
  • Critical Limb Ischemia - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 142
    Critical Limb Ischemia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia - Pipeline Review, H2 2018, provides an overview of the Critical Limb Ischemia (Cardiovascular) pipeline landscape. Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease (PAD). It is caused by chronic inflammatory processes associated with atherosclerosis that resul......
  • Atherosclerosis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 244
    Atherosclerosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Pipeline Review, H2 2018, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape. Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive build up of plaque around the artery wall. The disease disrupts......
  • Stroke - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 544
    Stroke - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2018, provides an overview of the Stroke (Cardiovascular) pipeline landscape. Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear sudd......
  • Arterial Thrombosis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 54
    Arterial Thrombosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H2 2018, provides an overview of the Arterial Thrombosis (Cardiovascular) pipeline landscape. Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin and coldness. Depending on where the clot forms, art......
  • Global Congestive Heart Failure Drugs Market Size, Status and Forecast 2018-2025
    Published: 06-Sep-2018        Price: US 3900 Onwards        Pages: 109
    This report focuses on the global Congestive Heart Failure Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Congestive Heart Failure Drugs development in United States, Europe and China. In 2017, the global Congestive Heart Failure Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study......
  • Global Myocardial Infarction Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 30-Aug-2018        Price: US 3480 Onwards        Pages: 130
    Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which are used to treat heart attacks are known as myocardial infarction drugs. The reduced blood flow further causes blockage in the supply of oxygen to the heart, which is due to atherosclerosis, a process in which the plaque is formed on the inside wall of the coronary vein or one of its minor branches. Myocardial infraction occur......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs